GANEO - Guidelines Advisory Network Africa

MENU
Go back to ALICE

The managed hypertensive: the costs of blood pressure control in a Nigerian town

Posted on 01 January 2012

Summary of findings

The lower treatment cost per patient reaching blood pressure target was observed with methyl Dopa and diuretics: 8 and 12.8 Naira per patient reaching target, respectively. The cost per patient reaching blood pressure target with dual therapy varied from 32 to 35 Naira. The study also suggests that the economic burden of anti-hypertensive therapy is substantial.


Intervention

Anti-hypertensive therapy : diuretics (D); calcium channel blockers (CCB) ; angiotensin converting enzyme inhibitor (ACEI) ; beta blockers (BB) ; centrally acting drugs (CA) ; combination therapy : D+ACEI+CA+CCB; D+ACEI+CCB; CCB+CA+ACEI

Disease classification

Hypertension. 17.6% in stage 1 (systolic blood pressure 140 – 159 mmHg or diastolic 90 – 99 mmHg; 82.4% stage 2 (systolic blood pressure ≥ 160 mmHg; diastolic ≥ 100 mmHg) 

Country of the study

Nigeria

Source of effectiveness

Number of patient reaching blood pressure target

Type of cost

Direct treatment cost of treatment; indirect cost = cost of transportation to hospital

Source of cost

Treatment cost : Price of hospital or community pharmacies as of September, 2010

Currency

Naira

Cost per responders

Average treatment cost per patient reaching the target blood pressure : CA = 8 Naira per responders; diuretics alone = 12.8 Naira per responders; D+CCB = 31.7 Naira per responder; D+CA = 32.3 Naira per responder; D + ACEI = 34.7 Naira per responder; D+ BB = 35 Naira per responder; D+CCB+ CA = 77.5 Naira per responder; D + CCB + ACEI = 161.5 Naira per responder; ACEI alone or CCB alone =  750 Naira per responder

References

Ilesanmi OS, Ige OK, Adebiyi AO. The managed hypertensive: the costs of blood pressure control in a Nigerian town. Pan Afr Med J. 2012;12:96

 

Hypertension education and adherence in South Africa: a cost-effectiveness analysis of community health workers.